Close Menu
August 29, 2019
Sponsored by

Biobanking at Scale to Support Precision Medicine


Professor of Genetics, Rutgers University
COO, RUCDR Infinite Biologics, Human Genetics Institute of NJ

This webinar outlines how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

RUCDR Infinite Biologics, a unit of the Human Genetics Institute of New Jersey, has been perfecting the science of biobanking, bioprocessing, and analytics. In this webinar, Andrew Brooks introduces how RUCDR Infinite Biologics has created novel workflows to address precision medicine applications and presents an overview of these workflows, cutting edge analytical approaches, and robust biomaterial storage processes.  

With a focus on primary sample processing and new technological innovations allowing for efficient and cost-effective nucleic acid extraction, he describes how discovery processes are maximized, and precious biomaterial resources are protected for future analyses in both research and clinical applications.

Sponsored by

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Sponsored by

Genomics is a key element in the potential of precision medicine to transform oncology. 

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Sponsored by

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.